📖 Your Q2 Earnings Guide: Discover the Stocks ProPicks AI Highlights to Jump Post-EarningsRead more

Catalyst Pharmaceuticals Inc (CPRX)

NASDAQ
Currency in USD
Disclaimer
16.940
+0.220(+1.32%)
Closed
After Hours
16.9400.000(0.00%)
CPRX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
16.69017.020
52 wk Range
11.55017.495
Prev. Close
16.72
Open
16.8
Day's Range
16.69-17.02
52 wk Range
11.55-17.495
Volume
527,322
Average Vol. (3m)
1,074,899
1-Year Change
24.01%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
CPRX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
27.286
Upside
+61.074%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

People Also Watch

56.17
INSW
+1.70%
127.96
ACLS
-4.57%
796.78
SMCI
-0.60%
279.95
CDNS
+0.76%
126.22
NTAP
+0.10%

Catalyst Pharmaceuticals Inc Company Profile

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was founded in 2002 and is based in Coral Gables, Florida.

Employees
82
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.